Triamcinolone acetonide release modelling from novel bilayer mucoadhesive films: an in vitro study
- PMID: 37150730
- DOI: 10.1016/j.dental.2023.04.005
Triamcinolone acetonide release modelling from novel bilayer mucoadhesive films: an in vitro study
Abstract
Objectives: Recurrent aphthous stomatitis (RAS) is a painful disorder that commonly appears as ulcers on the oral mucosa, lasting ∼two weeks (minor) to months (major and herpetiform). Current treatment often necessitates the use of topical steroids in the form of pastes, mouthwashes, or gels, but these forms are often ineffective due to inadequate drug contact time with the ulcers. In this study, the performance of novel bilayer mucoadhesive buccal films loaded with triamcinolone acetonide (TA) has been evaluated for targeted drug delivery.
Methods: Experimental mucoadhesive films of hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol (PVA), and polyvinyl pyrrolidone (PVP) were prepared by the solvent casting method, and ethyl cellulose (EC) was applied as the backing layer. The films were characterized for their physical properties, including swelling index (SI), folding endurance, adhesion force with porcine buccal mucosa, residence time and in-vitro drug release.
Results: The data showed that the films were flexible with folding endurance> 300 times. With porcine buccal mucosa i) suitable adhesion forces were obtained (between 2.72 and 4.03 N), ii) residence times of> 24 h, and iii) surface pH between 6.8 and 7.1 indicating they would be non-irritant. All films released 100% TA over 6 h, but with varying profiles. The release of TA (over 6 h) from PVP-free films followed Fickian diffusion kinetics (diffusion-controlled release of drug), whereas the mechanism of release from PVP-containing films was found to be a superposition of diffusion-controlled and erosion-controlled release (anomalous).
Significance: The developed films hold great promise for potentially treating RAS and other oral conditions.
Keywords: Bilayer buccal films; Drug release kinetics modelling; Hydroxypropyl methylcellulose (HPMC); Mucoadhesive films; Recurrent aphthous stomatitis; Triamcinolone acetonide.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Permeability of triamcinolone acetonide, released from mucoadhesive films, through a buccal mucosa-mimetic barrier: Permeapad™.Dent Mater. 2024 Sep;40(9):1372-1377. doi: 10.1016/j.dental.2024.06.016. Epub 2024 Jun 19. Dent Mater. 2024. PMID: 38902145
-
Promote Recurrent Aphthous Ulcer Healing with Low Dose Prednisolone Bilayer Mucoadhesive Buccal Film.Curr Drug Deliv. 2017;14(1):123-135. doi: 10.2174/1567201813666160316122548. Curr Drug Deliv. 2017. PMID: 26980427
-
Design, Development and In vitro/Ex vivo Evaluation of Mucoadhesive Buccal Film of Benzydamine Hydrochloride for the Effective Treatment of Aphthous Stomatitis.Recent Pat Drug Deliv Formul. 2018;12(4):277-294. doi: 10.2174/1872211313666190128151038. Recent Pat Drug Deliv Formul. 2018. PMID: 30706830
-
Evolution of Drug Delivery Systems for Recurrent Aphthous Stomatitis.Drug Des Devel Ther. 2021 Sep 27;15:4071-4089. doi: 10.2147/DDDT.S328371. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34616142 Free PMC article. Review.
-
Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems.PDA J Pharm Sci Technol. 2012 Sep-Oct;66(5):466-500. doi: 10.5731/pdajpst.2012.00877. PDA J Pharm Sci Technol. 2012. PMID: 23035030 Review.
Cited by
-
Characteristics, preparation and applicability in oral delivery systems of cellulose ether-based buccal films.Drug Deliv. 2025 Dec;32(1):2525223. doi: 10.1080/10717544.2025.2525223. Epub 2025 Jul 11. Drug Deliv. 2025. PMID: 40641388 Free PMC article. Review.
-
Novel tetrahydrocurcumin integrated mucoadhesive nanocomposite κ-carrageenan/xanthan gum sponges: a strategy for effective local treatment of oral cancerous and precancerous lesions.Drug Deliv. 2023 Dec;30(1):2254530. doi: 10.1080/10717544.2023.2254530. Drug Deliv. 2023. PMID: 37668361 Free PMC article.
-
Niosome as a Drug Delivery Carrier for Sorafenib: Preparation, Investigation of Physicochemical Properties, and In Vitro Effects on HepG2 Cell Line.Adv Pharm Bull. 2024 Dec 30;14(4):836-845. doi: 10.34172/apb.43228. Epub 2024 Oct 2. Adv Pharm Bull. 2024. PMID: 40190669 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous